期刊文献+

氨基末端B型利钠肽前体监测对老年心衰患者的预后评估价值 被引量:5

Value of prognosis evaluation of NT-proBNP in elderly patients with heart failure
下载PDF
导出
摘要 目的动态监测氨基末端B型利钠肽前体(NT-proBNP)水平,探讨其对老年充血性心力衰竭患者的预后评估价值。方法前瞻性选取186例老年心衰患者,分别于入院时、出院时、出院后4周测定血浆NT-proBNP(NT-proBNP1、NT-proBNP2、NT-proBNP3)水平,观察心衰患者心源性再住院及死亡等事件,评价NT-proBNP对老年充血性心衰患者预后判定的价值。结果 186例患者平均随访(261±23.6)d,心源性再发组及非再发组的NT-proBNP1及NT-proBNP3水平无明显差异。再发组NT-proBNP2水平显著高于非再发组(均P<0.01),心源性死亡组NT-proBNP2水平也显著高于心衰再入院组(均P<0.01),再发组NT-proBNP变化指数显著低于非再发组(P<0.01)。Cox多元回归分析显示,NT-proBNP2、住院期间NT-proBNP变化指数、患者的年龄、既往心衰史、贫血、入院时NYHA分级、合并心房颤动、室性心动过速是反映老年心力衰竭患者心源性死亡、再住院的独立的相关因素。结论动态监测入院时及出院时NT-proBNP,计算NT-proBNP变化指数,有利于对老年心力衰竭患者预后做出评估。 Objective To detect the level of N-terminal pro-brain natriuretic peptide(NT-proBNP) and analyze its value of prognosis evaluation in elderly patients with heart failure.Methods The data of 186 elderly patients with heart failure were analyzed prospectively.NT-proBNP(NT-proBNP 1,NT-proBNP 2 and NT-proBNP 3) levels were assayed when they admitted in hospital,discharged from hospital and after one month in order to evaluate the predictive value of NT-proBNP for prognosis of heart failure.The cardiogenic re-admission and death events were observed.Results Heart patients were followed up for average(261±23.6) d.Compared patients with cardiovascular events and patients without cardiovascular events,there were no statistical differences in NT-proBNP1 and NT-proBNP3.NT-proBNP2 were higher in patients with cardiovascular events than without cardiovascular events group(P〈0.01).NT-proBNP2 were also higher in death group than re-admission group(P〈0.01).Variability index of NT-proBNP1 were lower in patients with cardiovascular events than in patients without cardiovascular events(P〈0.01).Cox proportional hazard regression model analysis showed that NT-proBNP2,changes in NT-proBNP during hospitalization,advance age,previous history of heart failure,anemia,NYHA class,atrial fibrillation and ventricular tachycardia were determinants for patients’cardiogenic death and re-admission.Conclusion Monitoring NT-proBNP in elderly patients at the time of hospitalization and leave hospital could predict the prognosis of patient s with heart failure.
出处 《临床军医杂志》 CAS 2012年第2期310-313,共4页 Clinical Journal of Medical Officers
关键词 氨基末端脑钠肽前体 心力衰竭 预后 老年 N-terminal pro-brain natriuretic peptide heart failure prognosis aged
  • 相关文献

参考文献9

  • 1甘志远,唐丽玲.2000至2008年医院死亡病例死因分析[J].中国医药指南,2010,8(1):113-114. 被引量:11
  • 2Choi DJ, Han S, Jeon ES, et al. Characteristics, outcomes andpredictors of long-term mortality for patients hospitalized for acute heart failure:a report from the korean heart failure registry [ J ]. Korean Circ J, 2011,41(7) :363-371.
  • 3Alehagen U, Dahlstrǒm U. Can NT-proBNP predict risk of cardio- vascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart ailure[J]. Int J Cardiol, 2009,133(2) :233-240.
  • 4MacGowan GA,Neely D,Peaston R,et al. Evaluation of NT-proBNP to predict outcomes in advanced heart failure[J]. Rev Port Cardiol, 2007,26 (5) :535-545.
  • 5Sedlak TL, Chandavimol M, Calleja A, et al. The ability of heart failure specialists to accurately predict NT-proBNP levels based on clinical assessment and a previous NT-preBNP measurement [ J ]. Open Cardiovasc Med J, 2008, 2:36-40.
  • 6Ferreira S, Almeida R, Guerrero H, et al. Prognosis of decompensated heart failure: role of NT-proBNP [J ]. Int J Clin Pract,2010,64(7) :892-899.
  • 7O' Brien R J, Squire IB, Demme B, et al. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF [ J ]. Eur J Heart Fail, 2003, 5 ( 4 ) : 499-506.
  • 8Masson S, Latini R, Anand IS, et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal pmBNP in a large population of patients with chronic and symptomatic heart failure : the Valsartan Heart Failure (Val-HeFr) data[J]. Clin Chem, 2006,52(8) :1528-1538.
  • 9Bettencourt P, Azevedo A, Pimenta J, et al. N-Terminal-Pro-Brain Natriuretic Peptide predicts outcome after hospital discharge in heart failure patients [J]. Circulation, 2004, 110 : 2168-2174.

二级参考文献4

共引文献10

同被引文献54

  • 1郑晓丽.缬沙坦治疗慢性心衰观察[J].临床军医杂志,2010,38(4):562-562. 被引量:10
  • 2戴维靖,姚渭清.血清N末端脑利钠肽前体与肌钙蛋白对婴幼儿充血性心力衰竭的诊断价值研究[J].实用心脑肺血管病杂志,2010,18(12):1750-1752. 被引量:4
  • 3汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 4无.血管紧张素转换酶抑制剂在心血管病中应用中国专家共识[J].中华心血管病杂志,2007,35(2):97-106. 被引量:133
  • 5Wong M, Staszewasky L, Latini R, et al. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study [ J ]. J Am Coll Cardiol, 2002, 40 (5) : 970 -975.
  • 6McMurray JJ, Ostergren J, Swedberg K, et al. Effects of cande- sartan in patients with chronic heart failure and reduced left-ven- tricular systolic function taking' angiotensin converting enzyme in- hibitors: the CHARM-Added trial [ J]'. Lancet, 2003, 362 (9386) :767 -771.
  • 7Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guide- line update for the diagnosis and management of chronic heart failure in the adult [ J]. Circulation, 2005, 112 ( 12 ) : 154 - 235.
  • 8Athanasopoulos LV, Dritsas A, Doll HA, et al. Comparative value of NYHA functional class and quality of life questionnaire scores in assessing heart failure [ J ]. J Cardiopulm Rehabil Prev, 2010, 30(2) : 101 - 105.
  • 9The SOLVD Investigattors. Effect of enalapril on mortality and the development of heart failure in asympto-matic patients with reduced left ventricular ejection fractions [ J]. N Engl J Med, 1992, 327(10) : 685 -691.
  • 10Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesar- tan in patients with chronic heart failure and reduced left-ven- tricular systolic function intolerant to angiotensin-converting-en- zyme inhibitors: the CHARM-Alternative trial[J]. The Lancet, 2003, 362(9386) :772 -776.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部